4.7 Review

Glutathione: An Old and Small Molecule with Great Functions and New Applications in the Brain and in Alzheimer's Disease

Journal

ANTIOXIDANTS & REDOX SIGNALING
Volume 35, Issue 4, Pages 270-292

Publisher

MARY ANN LIEBERT, INC
DOI: 10.1089/ars.2020.8129

Keywords

advanced glycation end-products; ferroptosis; glutaredoxin; thioredoxin; nanoparticles

Funding

  1. Research Chair Louise & Andre' Charron on Alzheimer's disease
  2. Foundation ArmandFrappier
  3. Fonds de Recherche du Que'bec-Nature et Technologies (FRQNT)
  4. NSERC

Ask authors/readers for more resources

Glutathione plays a significant role as an antioxidant in the brain related to Alzheimer's disease, with alterations in its levels correlated with cognitive decline. Strategies have been developed to restore its intracellular level, but no significant benefits have been reported in clinical trials so far. Future directions include utilizing GSH-coupled nanocarriers for brain delivery and investigating its presence in exosomes for potential intercellular transfer.
Significance: Glutathione (GSH) represents the most abundant and the main antioxidant in the body with important functions in the brain related to Alzheimer's disease (AD). Recent Advances: Oxidative stress is one of the central mechanisms in AD. We and others have demonstrated the alteration of GSH levels in the AD brain, its important role in the detoxification of advanced glycation end-products and of acrolein, a by-product of lipid peroxidation. Recent in vivo studies found a decrease of GSH in several areas of the brain from control, mild cognitive impairment, and AD subjects, which are correlated with cognitive decline. Critical Issues: Several strategies were developed to restore its intracellular level with the l-cysteine prodrugs or the oral administration of gamma-glutamylcysteine to prevent alterations observed in AD. To date, no benefit on GSH level or on oxidative biomarkers has been reported in clinical trials. Thus, it remains uncertain if GSH could be considered a potential preventive or therapeutic approach or a biomarker for AD. Future Directions: We address how GSH-coupled nanocarriers represent a promising approach for the functionalization of nanocarriers to overcome the blood/brain barrier (BBB) for the brain delivery of GSH while avoiding cellular toxicity. It is also important to address the presence of GSH in exosomes for its potential intercellular transfer or its shuttle across the BBB under certain conditions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available